DanielBenedictSchmolzeMD

PubMed

• Association BetweenF-FDG PET Activity and HER2 Status in Breast Cancer Brain Metastases.
  Jonathan R Young, Julie A Ressler, Joanne E Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T Chen> ;Nuclear Medicine and Molecular Imaging. 2024 May 1
• Tumor heterogeneity and clinically invisible micrometastases in metastatic breast cancer-a call for enhanced surveillance strategies.
  Eliza R Bacon, Kena Ihle, Weihua Guo, Colt A Egelston, Diana L Simons, Christina Wei, Lusine Tumyan, Daniel Schmolze, Peter P Lee, James R Waisman> ;NPJ Precision Oncology. 2024 Mar 29
• 11 citations
  Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study.
  Sophia J Wagner, Daniel Reisenbüchler, Nicholas P West, Jan Moritz Niehues, Jiefu Zhu, Sebastian Foersch, Gregory Patrick Veldhuizen, Philip Quirke, Heike I Grabsch, P...> ;Cancer Cell. 2023 Sep 11
• 2 citations
  Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
  Zhen Han, Xiwei Wu, Hanjun Qin, Yate-Ching Yuan, Daniel Schmolze, Chingyu Su, Jasmine Zain, Lilach Moyal, Emmilia Hodak, James F Sanchez, Peter P Lee, Mingye Feng, Ste...> ;JCI Insight. 2023 Jul 10
• 6 citations
  Immunogenicity and efficacy of pembrolizumab and doxorubicin in a phase I trial for patients with metastatic triple-negative breast cancer.
  Colt A Egelston, Weihua Guo, Susan E Yost, Xuan Ge, Jin Sun Lee, Paul H Frankel, Yujie Cui, Christopher Ruel, Daniel Schmolze, Mireya Murga, Aileen Tang, Norma Martine...> ;Cancer Immunology, Immunotherapy. 2023 Sep 1
• 2 citations
  Profiling the Somatic Mutational Landscape of Breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics.
  Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Ada...> ;Cancer Research. 2023 Aug 1
• 1 citations
  Phase I Trial of Ipatasertib Plus Carboplatin, Carboplatin/Paclitaxel, or Capecitabine and Atezolizumab in Metastatic Triple-Negative Breast Cancer.
  Yuan Yuan, Susan E Yost, Yujie Cui, Christopher Ruel, Mireya Murga, Aileen Tang, Norma Martinez, Daniel Schmolze, James Waisman, Niki Patel, Lalit Vora, Lusine Tumyan,...> ;The Oncologist. 2023 Jul 5
• Complete response to chemoimmunotherapy with bevacizumab in synchronous multiple primary cancers: pulmonary adenocarcinoma and sarcomatoid carcinoma.
  Diogo Garcia, Isa Mambetsariev, Jeremy Fricke, Daniel Schmolze, Michelle Afkhami, Rifat Mannan, Pauline Kim, Shaira Therese Dingal, Bao Nguyen, Razmig Babikian, Yuman ...> ;Cold Spring Harbor Molecular Case Studies. 2023 Apr 1
• 1 citations
  Association of Relative Cerebral Blood Volume from Dynamic Susceptibility Contrast-Enhanced Perfusion MR with HER2 Status in Breast Cancer Brain Metastases.
  Jonathan R Young, Julie A Ressler, Mark S Shiroishi, Joanne E Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T Chen> ;Academic Radiology. 2023 Sep 1
• 2 citations
  Phase 2 prospective open label study of neoadjuvant nab-paclitaxel, trastuzumab, and pertuzumab in patients with HER2-positive primary breast cancer.
  Sayeh M Lavasani, George Somlo, Susan E Yost, Paul H Frankel, Christopher Ruel, Yujie Cui, Mireya Murga, Aileen Tang, Norma Martinez, Laura Kruper, Lusine Tumyan, Dani...> ;Cancer. 2023 Mar 1
• 2 citations
  Association of lesion contour and lesion composition on MR with HER2 status in breast cancer brain metastases.
  Jonathan R Young, Julie A Ressler, Joanne E Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T Chen> ;Magnetic Resonance Imaging. 2023 Feb 1
• 4 citations
  Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer.
  Jin Sun Lee, Susan E Yost, Sierra Min Li, Yujie Cui, Paul H Frankel, Yate-Ching Yuan, Daniel Schmolze, Colt A Egelston, Weihua Guo, Mireya Murga, Helen Chang, Linda Bo...> ;Cancers. 2022 Jun 28
• 5 citations
  Molecular Assessment of HER2 to Identify Signatures Associated with Therapy Response in HER2-Positive Breast Cancer.
  Adam L Maddox, Matthew S Brehove, Kiarash R Eliato, Andras Saftics, Eugenia Romano, Michael F Press, Joanne Mortimer, Veronica Jones, Daniel Schmolze, Victoria L Seewa...> ;Cancers. 2022 Jun 4
• 11 citations
  Hyperthermic Intraperitoneal Chemotherapy-Induced Molecular Changes in Humans Validate Preclinical Data in Ovarian Cancer.
  Thanh H Dellinger, Ernest S Han, Mustafa Raoof, Byrne Lee, Xiwei Wu, Hyejin Cho, Ting-Fang He, Peter Lee, Marianne Razavi, Winnie S Liang, Daniel Schmolze, Saul J Pric...> ;JCO Precision Oncology. 2022 Mar 1
• 14 citations
  Tumor-infiltrating exhausted CD8+ T cells dictate reduced survival in premenopausal estrogen receptor-positive breast cancer.
  Colt A Egelston, Weihua Guo, Jiayi Tan, Christian Avalos, Diana L Simons, Min Hui Lim, Yinghui J Huang, Michael S Nelson, Arnab Chowdhury, Daniel B Schmolze, John H Yi...> ;JCI Insight. 2022 Feb 8
• 1 citations
  Molecular Imaging of HER2 in Patient Tissues with Touch Prep-Quantitative Single Molecule Localization Microscopy.
  Devin L Wakefield, Steven J Tobin, Daniel Schmolze, Tijana Jovanovic-Talisman> ;Methods in Molecular Biology. 2022 Jan 1
• 3 citations
  Establishment of a whole slide imaging-based frozen section service at a cancer center.
  Sue Chang, Evita Sadimin, Keluo Yao, Stanley Hamilton, Patricia Aoun, Raju Pillai, David Muirhead, Daniel Schmolze> ;Journal of Pathology Informatics. 2022 Jan 1
• 7 citations
  MicroRNA Regulation of T-Cell Exhaustion in Cutaneous T Cell Lymphoma.
  Zhen Han, Renee Estephan, Xiwei Wu, Chingyu Su, Yate-Ching Yuan, Hanjun Qin, Sung Hee Kil, Corey Morales, Daniel Schmolze, James F. Sanchez, Lei Tian, Jianhua Yu, Marc...> ;The Journal of Investigative Dermatology. 2021 Nov 11
• 2 citations
  Stressed out and fed up: The effect of stress on maternal feeding behaviors and the moderating role of executive function.
  Stacey N. Doan, Shruthi Venkatesh, Isabel Mendiola, Patricia A. Smiley, Daniel Schmolze> ;Appetite. 2021 Oct 16
• 5 citations
  Performance of enhancement on brain MRI for identifying HER2 overexpression in breast cancer brain metastases
  Jonathan R. Young, Julie A. Ressler, Joanne E. Mortimer, Daniel Schmolze, Mariko Fitzgibbons, Bihong T. Chen> ;European Journal of Radiology. 2021 Sep 11
• 33 citations
  Phase I/II trial of palbociclib, pembrolizumab and letrozole in patients with hormone receptor-positive metastatic breast cancer.
  Yuan Yuan, Jin Sun Lee, Susan E. Yost, Paul Frankel, Christopher Ruel, Colt Egelston, Weihua Guo, Simran Padam, Aileen Tang, Norma Martinez, Daniel Schmolze, Cary A. P...> ;European Journal of Cancer. 2021 Jul 1
• 14 citations
  Spatial distribution of B cells and lymphocyte clusters as a predictor of triple-negative breast cancer outcome.
  Juliana C. Wortman, Ting-Fang He, Shawn Solomon, Robert Z. Zhang, Anthony Rosario, Roger Wang, Travis Y. Tu, Daniel Schmolze, Yuan Yuan, Susan E. Yost, Xuefei Li, Herb...> ;NPJ Breast Cancer. 2021 Jul 1
• 13 citations
  Raman spectroscopy and artificial intelligence to predict the Bayesian probability of breast cancer.
  Ragini Kothari, Veronica Jones, Dominique Mena, Viviana Bermúdez Reyes, Youkang Shon, Jennifer P Smith, Daniel Schmolze, Philip D. Cha, Lily L. Lai, Yuman Fong, Michae...> ;Scientific Reports. 2021 Mar 22
• 17 citations
  Pre-existing effector T-cell levels and augmented myeloid cell composition denote response to CDK4/6 inhibitor palbociclib and pembrolizumab in hormone receptor-positi...
  Colt Egelston, Weihua Guo, Susan E. Yost, Jin Sun Lee, David Rose, Christian Avalos, Jian Ye, Paul Frankel, Daniel Schmolze, James Waisman, Peter P. Lee, Yuan Yuan> ;Journal for Immunotherapy of Cancer. 2021 Mar 1
• 18 citations
  Towards integration of 64Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer.
  Angela M. Jarrett, David A. Hormuth, Vikram Adhikarla, Prativa Sahoo, Daniel Abler, Lusine Tumyan, Daniel Schmolze, Joanne E. Mortimer, Russell C. Rockne, Thomas E. Ya...> ;Scientific Reports. 2020 Nov 25
• Join now to see all

Journal Articles

• Distribution of Cholesterol and HER2 in Patient Breast Cancer Cells using Quantitative Single Molecule Localization Microscopy  
  Brehove, M.S., Tobin, S.J., Wakefield, D.L., Jones, V., Liu, X., Schmolze, D.B., Jovanovic-Talisman, T, Biophysical Journal, 1/1/2019
• Single molecule localization microscopy coupled with touch preparation for the quantification of trastuzumab-bound HER2  
  Tobin, S.J., Wakefield, D.L., Jones, V., Liu, X., Schmolze, D.B., Jovanovic-Talisman, T., Scientific Reports, 1/1/2018
• A System for Automated Adequacy Assessment of Thyroid Fine Needle Aspiration Samples  
  Schmolze, D.B., Fischer, A.H., Archives of Pathology and Laboratory Medicine, 1/1/2018
• Identification of Tissue Specific DNA Methylation Signatures for Thyroid Nodule Diagnostics  
  Yim, J., Choi, A., Li, A., Qin, H., Chang, S., Tong, S-W., Chu, P., Kim, B-W., Schmolze, D.B., Lew, R., Ibrahim, Y., Poroyko, V., Salvatierra, S., Baker, A., Wang, J.,..., Clinical Cancer Research, 1/1/2018
• Dual mTOR Kinases MLN0128 Inhibitor Sensitizes HR+/HER2+ Breast Cancer Patient-derived Xenografts to Trastuzumab or Fulvestrant  
  Hsu, P., Wu, V. S., Kanaya, N., Petrossian, K., Hsu, H., Ngyuyen, D., Schmolze, D.B., Kai, M., Liu, C., Lu, H., Chu, P., Vito. C.A, Kruper, L., Mortimer, J. Chen., S., Clinical Cancer Research, 1/1/2018
• Complete regression of cutaneous metastases with systemic immune response in a patient with triple negative breast cancer receiving p53MVA vaccine with pembrolizumab  
  Yuan, Y., Kos, F.J, He, T., Yin, H.H., Li, M., Har, Hardwick, N., Zurcher, K., Schmolze, D.B., Lee, P., Pillai, R.K., Chung, V., Diamond, D.D., OncoImmunology, 1/1/2017
• Crowdsourcing scoring of immunohistochemistry images: Evaluating Performance of the Crowd and an Automated Computational Method  
  Irshad, H., Oh, E.Y., Schmolze, D.B., Quintana L.M., Collins, L., Tamimi, R.M., Beck, A.H., Nature Scientific Reports, 1/1/2017
• A 63 Year-Old Man With Rapidly Progressive Dementia  
  Hale, A., Geerling, J., Schmolze, DB., Pfannl, R., Karchmer, AW, Clinical Infectious Diseases, 1/1/2016
• Direct comparison between confocal and multiphoton microscopy for rapid histopathological evaluation of unfixed human breast tissue  
  Yoshitake, T., Giacomelli, G.G., Cahill, L.C., Schmolze, D.B., Vardeh, H., Faulkner-Jones, B.E., Connolly, J.L., Fujimoto, J. G., Journal of Biomedical Optics, 1/1/2016
• Using Point of Care Glucose Meters in Critically Ill: Assessing Meter Performance in the Clinical Context  
  Schmolze, D.B., Horowitz, G.L., Tolan, N.V., Point of Care: The Journal of Near-Patient Testing and Technology, 1/1/2016
• Assessment of breast pathologies using nonlinear microscopy  
  Tao, Y. K., Shen, D., Sheikine, Y., Ahsen, O. O., Wang, H. H., Schmolze, D. B., Fujimoto, J. G., et al, Proceedings of the National Academy of Sciences, 1/1/2014
• Value of Additional Level Sections in the Evaluation of Lymph Nodes for Endometrial Carcinoma Staging  
  Schmolze, D.B., Awtrey, C. S., & Hecht, J. L., American Journal of Clinical Pathology, 1/1/2013
• Characterization and Analysis of the Composition and Dynamics of the Mammalian Riboproteome  
  Reschke, M., Clohessy, J. G., Seitzer, N., Goldstein, D. P., Breitkopf, S. B., Schmolze, D. B., Pandolfi, P. P., et al, Cell Reports, 1/1/2013
• Advances in microscopy techniques  
  Schmolze, D. B., Standley, C., Fogarty, K. E., & Fischer, A. H., Archives of Pathology & Laboratory Medicine, 1/1/2011
• Join now to see all

Abstracts/Posters

• Relations between sleep and inflammation in African American and White young adults: Testing mediating and moderating mechanisms.
  Doan, S.N., Fuller-Rowell, T., Schmolze, D.B., Seewaldt, V., AACR (American Association for Cancer Research) Science of Cancer Disparities Annual Meeting, 1/1/2018
• Leiomyoadenomatoid Tumor: A Collision Tumor or a Variant of Adenomatoid Tumor?
  Al-Sannaa, G., El-Zaateri, Z., Andino, L., Schmolze, D.B., Chapman, D., Ayala, A., Ro, J., CAP Annual Meeting, 1/1/2018
• Segmentation-based Data Augmentation in Deep Networks for Magnification Invariant Breast Cancer Detection.
  Jonnalagedda, P., Schmolze, D.B., Bhanu, B., UC Riverside Bioengineering Symposium, 1/1/2018
• Latent Class Modeling of Childhood BMI Trajectories.
  Schmolze, D.B, Doan, S.N., Evans, G., Life History Research Society Annual Meeting, 1/1/2018
• Evaluation of The Tumor Microenvironment Using Multiplex Immunohistochemistry.
  Himchack, E., Muirhead, D., Lewallen, M., Schmolze, D.B., Song, J., Kim, Y., Nathwani, B., Weisenburger, D., Herrera, A., Pillai, R., United States and Canadian Academy of Pathology Annual Meeting, 1/1/2018
• Mutational and Immune Profiling of Metaplastic Breast Cancer: Correlation with Survival.
  Afkhami, M., Schmolze, D.B., Yost, S., Frankel, P., Dagis, A., Louie, C., Pillai, R., Aoun, P., Yuan, Y, United States and Canadian Academy of Pathology Annual Meeting, 1/1/2018
• Prognostic significance of PD-L1 expression in cancer, stromal, and immune cells in triple-negative breast cancer.
  Behrendt, C.E., Schmolze, D.B., Lee, P.P., Apple, S., United States and Canadian Academy of Pathology Annual Meeting, 1/1/2018
• Early Hallmarks for Tumor-induced Dysfunctional Sentinel Lymph nodes in Breast Cancer.
  He, T-F., Tu, T.Y., Wang, R., Rosario, A., Solomon, S., Wortman, J.C., Yu, C.C., Apple, S.K, Schmolze, D.B., Yuan, Y., Lee, P.P., Molecular Medicine Tri-Con Annual Meeting, 1/1/2018
• A novel super-resolution microscopy approach to determine the HER2 status of breast cancer tissue.
  Tobin, S.J, Wakefield, D.L., Jones, V., Liu, X., Schmolze, D.B., Jovanovic-Talisman, T., City of Hope RSO Advance Meeting, 1/1/2018
• A phase II clinical trial of the combination of pembrolizumab and selective androgen receptor modulator GTx-024 in patients with advanced androgen receptor positive tr...
  Yuan, Y., Frankel, P., Synold, T., Lee, P., Yost, S., Martinez, N., Tang, A., Mendez, B., Schmolze, D.B., Apple, S., Hurria, A., Waisman, J., Somlo, G., Tank, N., Sedr..., San Antonio Breast Cancer Symposium Annual Meeting, 1/1/2017
• Immune profiling of paired primary and recurrent triple negative breast cancer.
  He, T-F., Yost, S., Schmolze, D.B., Wang, R., Rosario, A, Tu, T., Chu, P., Lee, P., Yuan, Y., San Antonio Breast Cancer Symposium Annual Meeting, 1/1/2017
• A System for Automated Adequacy Assessment of Thyroid Fine Needle Aspiration Samples.
  Schmolze, D.B., Fischer, A.H., United States and Canadian Academy of Pathology Annual Meeting, 1/1/2017
• Using Point-of-Care Glucose Meters in the Critically Ill: Assessing Meter Performance in the Clinical Context.
  Schmolze, D.B., Horowitz, G.L., Tolan, N.V., American Association of Clinical Chemistry Annual Meeting, 1/1/2015
• Join now to see all

Lectures

• AstraZeneca Interactive Tumor Board 
  1/21/2018
• Quantitative Super Resolution Microscopy with Touch Prep for HER2 Assessment in Breast Cancer 
  1/20/2018

Other

• MVPNets: Multi-Viewing Path Deep Learning Neural Networks for Magnification Invariant Diagnosis in Breast Cancer. 
  Jonnalagedda, P., Schmolze, D.B., Bhanu, B, IEEE BIBE 2018
  1/1/2018
• Clinical Pathology Improvement Program-Parvovirus Infection and Transient Aplastic Crisis. 
  Schmolze, D.B., cap.org
  1/1/2014
• EMDomics: Earth Mover's Distance for Differential Analysis of Genomics Data. 
  Schmolze, D.B., Beck, A.H., and Nabavi, S., R Package Version 0.99.0.
  http://cran.rproject.org/web/packages/saps/
  1/1/2014
• ega: Error Grid Analysis. 
  Schmolze, D.B., R Package Version 1.0.0.
  http://cran.rproject.org/web/packages/ega/
  1/1/2014
• saps: Significance Analysis of Prognostic Signatures. 
  Schmolze, D.B., Beck, A. H.., and Haibe-Kains, B., R Package Version 1.0.0.
  http://cran.rproject.org/web/packages/saps/
  1/1/2014
• Uniting Student Musicians and Patients: A Quality Improvement Project. 
  Schmolze, D.B., Makowski, S., University of Massachusetts Medical School, Senior Scholars Program
  http://escholarship.umassmed.edu/ssp/116
  1/1/2011
• Join now to see all